Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.
Radar Therapeutics has raised $13.4M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
Radar Therapeutics's investors include Pear VC, Eli Lilly, Pioneer Fund, KdT Ventures, Mei Z..
Radar Therapeutics is headquartered in Berkeley, United States.
Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.
Radar Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Radar Therapeutics — Funding & Investors." VCBacked, May 23, 2024, https://www.vcbacked.co/company/radar-therapeutics. Accessed July 19, 2026.
VCBacked. (2024). Radar Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/radar-therapeutics
{{cite web |title=Radar Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/radar-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated